Processing

Please wait...

Settings

Settings

Goto Application

1. WO2013001544 - ANTI-THROMBOTIC COMPOUNDS

Publication Number WO/2013/001544
Publication Date 03.01.2013
International Application No. PCT/IN2012/000021
International Filing Date 06.01.2012
IPC
C07D 495/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
495Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
A61K 31/4365 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
4365the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
A61P 7/02 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
7Drugs for disorders of the blood or the extracellular fluid
02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
CPC
A61K 31/4365
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
4365the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61P 1/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
A61P 43/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
A61P 7/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
7Drugs for disorders of the blood or the extracellular fluid
02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
A61P 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
Applicants
  • IPCA LABORATORIES LIMITED [IN]/[IN] (AllExceptUS)
  • KUMAR, Ashok [IN]/[IN] (UsOnly)
  • SOUDAGAR, Satish Rajanikant [IN]/[IN] (UsOnly)
  • NELLITHANATH, Thankachen Byju [IN]/[IN] (UsOnly)
  • SAHAL, Gaurav [IN]/[IN] (UsOnly)
  • MATHUR, Arpana Prashant [IN]/[IN] (UsOnly)
  • GAWADE, Sanjay Pandurang [IN]/[IN] (UsOnly)
  • BHADRA, Dinesh Kanji [IN]/[IN] (UsOnly)
  • MOJE, Devki [IN]/[IN] (UsOnly)
Inventors
  • KUMAR, Ashok
  • SOUDAGAR, Satish Rajanikant
  • NELLITHANATH, Thankachen Byju
  • SAHAL, Gaurav
  • MATHUR, Arpana Prashant
  • GAWADE, Sanjay Pandurang
  • BHADRA, Dinesh Kanji
  • MOJE, Devki
Agents
  • P. ARUNA SREE
Priority Data
1848/MUM/201127.06.2011IN
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ANTI-THROMBOTIC COMPOUNDS
(FR) COMPOSÉS ANTI-THROMBOTIQUES
Abstract
(EN)
New compounds, namely, (7aS,2'S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
(FR)
Nouveaux composés, à savoir, (7aS,2'S)-2-oxoclopidogrel et ses sels de qualité pharmaceutique, pour traiter ou prévenir le thrombo-embolisme et/ou les maladies cardiovasculaires.
Latest bibliographic data on file with the International Bureau